Therapy News and Research

RSS

Most alternative treatments for autism lack reliable evidence

The most comprehensive quantitative review of research into complementary and alternative treatments for autism has found no strong evidence to support their use, and that the safety of these treatments was rarely assessed.

28 Aug 2025

Single gene discovery reveals key sex difference in immune response

A new study has uncovered a key difference between the immune system of males and females - and it comes down to a single gene.

28 Aug 2025

Wayne State project advances efforts toward automated diabetes care

Despite advances in insulin therapy and automated delivery systems, people with Type 1 diabetes (T1D) still face a daily struggle: manually dosing insulin before meals.

28 Aug 2025

New swallowable device enables noninvasive gut nerve stimulation

Scientists have long struggled with how to study the gut's vast nervous system - often called the body's 'second brain' - without damaging it.

28 Aug 2025

Hormone therapy type may influence postmenopausal cognitive health

The type of estradiol-based hormone therapy taken during and after menopause, such as patches or pills, may be associated with differences in memory performance, according to a study published on August 27, 2025, in Neurology, the medical journal of the American Academy of Neurology.

28 Aug 2025

Study finds minimal risk of second cancer in breast cancer survivors

For women diagnosed with early breast cancer, the long-term risk of developing a second primary cancer is low (around 2-3% greater than women in the general population), finds a study published by The BMJ today.

28 Aug 2025

Longitudinal study reveals how GLP-2 analog therapy transforms the intestinal environment

Researchers from Japan discover that glucagon-like peptide-2 (GLP-2) analogs can deeply and beneficially reshape the intestinal environment.

27 Aug 2025

Online cognitive behavioral therapy shows promise for treating bulimia nervosa

Bulimia nervosa (BN), or bulimia, is a mental health disorder characterized by binge eating and a fear of gaining weight, which drives people to try and avoid weight gain, usually by compensatory (vomiting etc.).

27 Aug 2025

Increasing numbers of bariatric surgery patients turn to GLP-1 drugs

Bariatric surgery is usually effective on its own for weight loss, but an increasing proportion of patients who undergo bariatric surgery start taking one of the new glucagon-like 1 peptide receptor agonist (GLP-1) weight-loss drugs in the years after their surgery, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

27 Aug 2025

Regenerative strategy offers hope for women with pelvic organ prolapse

Pelvic organ prolapse (POP) is a disorder that primarily affects older women who have experienced multiple vaginal childbirths.

27 Aug 2025

Gene editing therapy exa-cel improves quality of life in sickle cell disease and beta thalassemia

Treatment with exagamglogene autotemcel (exa-cel) led to robust and sustained improvements in quality of life for patients with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia, according to two studies published in Blood Advances.

27 Aug 2025

CURE GABA-A and Grann Pharmaceuticals announce global partnership to advance rare neurological therapies

CURE GABA-A (https://curegabaa.org/) is proud to announce a major new partnership with Grann Pharmaceuticals. CURE GABA-A is a nonprofit patient advocacy group founded by Monica Joanna Elnekaveh, mother to Eleanor Elnekaveh.

27 Aug 2025

Transcutaneous vagal nerve stimulation shows promise for gastrointestinal disorders

Imbalanced autonomic function, characterized by reduced vagal activity and sympathetic dominance, is increasingly recognized in various gastrointestinal (GI) disorders.

27 Aug 2025

Qureight's AI 3D imaging platform to support Calluna Pharma's Phase 2 AURORA study of CAL101 in idiopathic pulmonary fibrosis (IPF)

Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered imaging and clinical data curation platform, today announced that it has been selected by Calluna Pharma to support its Phase 2 AURORA study.

27 Aug 2025

Cognitive behavioral therapy linked to increased grey matter in emotion processing regions

Psychotherapy leads to measurable changes in brain structure. Researchers at Martin Luther University Halle-Wittenberg (MLU) and the University of Münster have demonstrated this for the first time in a study in "Translational Psychiatry" by using cognitive behavioral therapy.

27 Aug 2025

New oral antiretroviral shows potential as long-acting HIV pre-exposure prophylaxis

A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, Tracy Diamond and colleagues from Merck & Co., Inc., Rahway, NJ, USA, published August 26th in the open-access journal PLOS Biology.

26 Aug 2025

Vesalius: Harnessing artificial intelligence to decode cancer tissue architecture

Researchers at VCU Massey Comprehensive Cancer Center have developed a new computational tool called Vesalius, which could help clinicians understand the complex relationships between cancer cells and their surrounding cells, leading to potential discoveries regarding the development of hard-to-treat cancers.

26 Aug 2025

Therapy News and Research

Most alternative treatments for autism lack reliable evidence

Single gene discovery reveals key sex difference in immune response

Wayne State project advances efforts toward automated diabetes care

New swallowable device enables noninvasive gut nerve stimulation

Hormone therapy type may influence postmenopausal cognitive health

Study finds minimal risk of second cancer in breast cancer survivors

Longitudinal study reveals how GLP-2 analog therapy transforms the intestinal environment

Online cognitive behavioral therapy shows promise for treating bulimia nervosa

Increasing numbers of bariatric surgery patients turn to GLP-1 drugs

Regenerative strategy offers hope for women with pelvic organ prolapse

Gene editing therapy exa-cel improves quality of life in sickle cell disease and beta thalassemia

CURE GABA-A and Grann Pharmaceuticals announce global partnership to advance rare neurological therapies

Transcutaneous vagal nerve stimulation shows promise for gastrointestinal disorders

Qureight's AI 3D imaging platform to support Calluna Pharma's Phase 2 AURORA study of CAL101 in idiopathic pulmonary fibrosis (IPF)

Cognitive behavioral therapy linked to increased grey matter in emotion processing regions

New oral antiretroviral shows potential as long-acting HIV pre-exposure prophylaxis

Vesalius: Harnessing artificial intelligence to decode cancer tissue architecture

Virtual care program provides continuous cardiometabolic support for heart failure patients at home

Novel monoclonal antibodies show promise in preventing severe mpox disease

New light-based therapy shows promise for improving cognitive function in Alzheimer’s

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News